| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH3 MYH6 KIF1A MYO9A TMEM94 KIF1B CHD4 MYO5C DHX8 MDN1 HELZ DNAH5 DDX31 TCP1 DYNC2H1 KATNA1 KIF7 SLFN13 CHTF18 SLFN11 ATP5F1C | 3.26e-06 | 614 | 215 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.33e-06 | 118 | 215 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 1.21e-05 | 5 | 215 | 3 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 1.21e-05 | 5 | 215 | 3 | GO:0015501 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 KIF1A KIF1B CHD4 DHX8 MDN1 DNAH5 DDX31 TCP1 DYNC2H1 KATNA1 KIF7 SLFN13 CHTF18 SLFN11 ATP5F1C | 2.48e-05 | 441 | 215 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 KIF1A KIF1B CHD4 DHX8 MDN1 HRAS RAB29 DNAH5 RAB5C KRAS DDX31 NRAS TCP1 DYNC2H1 KATNA1 KIF7 SLFN13 CHTF18 SLFN11 MMUT ATP5F1C | 3.47e-05 | 775 | 215 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 CDHR5 FAT1 NRXN1 PCDH19 VIL1 PCDHB9 PON1 PCDHA3 RUNX1 SELENON CDH24 CDH22 DSG4 RAPGEF2 SCIN MCTP2 CDH5 PCDH7 CDH18 RAB11FIP3 | 6.29e-05 | 749 | 215 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH3 KIF1A KIF1B CHD4 DHX8 MDN1 HRAS RAB29 DNAH5 RAB5C KRAS DDX31 NRAS TCP1 DYNC2H1 KATNA1 KIF7 SLFN13 CHTF18 SLFN11 MMUT ATP5F1C | 1.11e-04 | 839 | 215 | 22 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH3 KIF1A KIF1B CHD4 DHX8 MDN1 HRAS RAB29 DNAH5 RAB5C KRAS DDX31 NRAS TCP1 DYNC2H1 KATNA1 KIF7 SLFN13 CHTF18 SLFN11 MMUT ATP5F1C | 1.13e-04 | 840 | 215 | 22 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH3 KIF1A KIF1B CHD4 DHX8 MDN1 HRAS RAB29 DNAH5 RAB5C KRAS DDX31 NRAS TCP1 DYNC2H1 KATNA1 KIF7 SLFN13 CHTF18 SLFN11 MMUT ATP5F1C | 1.13e-04 | 840 | 215 | 22 | GO:0016818 |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 1.15e-04 | 2 | 215 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TMEM94 TRPC6 SCN7A TRPV2 TRPM8 ASIC4 SLC23A2 CNGA2 CACNA1C TRPA1 SLC39A4 GRIK4 SLC1A1 SLC1A3 SLC1A6 | 1.65e-04 | 465 | 215 | 15 | GO:0046873 |
| GeneOntologyMolecularFunction | small GTPase binding | EPS8 RIN3 NCKAP1 PEX5 FGD5 RAB29 RANBP10 SYTL5 RIMS4 DOCK7 FGD6 RAB11FIP3 | 1.98e-04 | 321 | 215 | 12 | GO:0031267 |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 2.52e-04 | 12 | 215 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 5.09e-04 | 15 | 215 | 3 | GO:0005313 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 5.27e-04 | 35 | 215 | 4 | GO:0005343 | |
| GeneOntologyMolecularFunction | GTPase binding | EPS8 RIN3 NCKAP1 PEX5 FGD5 RAB29 RANBP10 SYTL5 RIMS4 DOCK7 FGD6 RAB11FIP3 | 5.56e-04 | 360 | 215 | 12 | GO:0051020 |
| GeneOntologyMolecularFunction | RNA polymerase III general transcription initiation factor binding | 6.83e-04 | 4 | 215 | 2 | GO:0001025 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 7.24e-04 | 38 | 215 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 8.00e-04 | 39 | 215 | 4 | GO:0070325 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 9.47e-04 | 70 | 215 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 1.13e-03 | 5 | 215 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | osmolarity-sensing monoatomic cation channel activity | 1.13e-03 | 5 | 215 | 2 | GO:1990760 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 1.23e-03 | 20 | 215 | 3 | GO:0015172 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TMEM94 TRPC6 SCN7A TRPV2 TRPM8 ASIC4 SLC23A2 CNGA2 CACNA1C TRPA1 SLC39A4 GRIK4 SLC1A1 SLC1A3 SLC1A6 ATP5F1C | 1.30e-03 | 627 | 215 | 16 | GO:0022890 |
| GeneOntologyMolecularFunction | osmosensor activity | 1.68e-03 | 6 | 215 | 2 | GO:0005034 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 1.86e-03 | 23 | 215 | 3 | GO:0005283 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.92e-03 | 120 | 215 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | DAB2IP SH3GLB2 CDHR5 ITGA2 NRXN1 PTPRM DMD PLXNB3 CNTN1 CDH24 CDH22 EMD TNR CDH5 CDH18 | 2.19e-03 | 599 | 215 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TMEM94 TRPC6 SCN7A TRPV2 TRPM8 ASIC4 SLC23A2 CNGA2 CACNA1C TRPA1 SLC39A4 GRIK4 SLC1A1 SLC1A3 SLC1A6 ATP5F1C | 2.32e-03 | 664 | 215 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 2.34e-03 | 7 | 215 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | cAMP binding | 2.38e-03 | 25 | 215 | 3 | GO:0030552 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CDHR5 FAT1 PTPRM PCDH19 PLXNB3 PCDHB9 PCDHA3 CDH24 CDH22 ROBO2 DSG4 CDH5 PCDH7 CDH18 | 1.21e-09 | 187 | 215 | 15 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell morphogenesis | DAB2IP EPS8 NCKAP1 KIF1A MYO9A ESRRB TRPC6 BRWD3 FAT1 NRXN1 PTPRM PTPRQ TRPV2 FGD5 DMD SLC23A2 PLXNA1 PLXNB3 CNTN1 VIL1 PLXNA3 LAMC2 SLC1A3 CDH24 CDH22 DOCK7 ROBO2 ELAVL4 RAPGEF2 TNR FGD6 CDH5 CDH18 EPHA5 PROX1 | 2.74e-08 | 1194 | 215 | 35 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 CDHR5 FAT1 NRXN1 PTPRM PCDH19 PLXNB3 PCDHB9 PCDHA3 CDH24 CDH22 ROBO2 DSG4 CDH5 PCDH7 CDH18 | 2.00e-07 | 313 | 215 | 16 | GO:0098742 |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 1.12e-06 | 3 | 215 | 3 | GO:0021627 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | DAB2IP EPS8 NCKAP1 KIF1A MYO9A TRPC6 CDHR5 ITGA2 NRXN1 HRAS TRPV2 DMD RAB29 PLXNA1 PLXNB3 CNTN1 VIL1 PLXNA3 KATNA1 MTOR ROBO2 ELAVL4 RAPGEF2 TNR RAB11FIP3 | 3.98e-06 | 863 | 215 | 25 | GO:0031344 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | DAB2IP EPS8 NCKAP1 ITGA2 NRXN1 HRAS TRPV2 DMD PLXNA1 PLXNB3 CNTN1 VIL1 PLXNA3 MTOR ROBO2 ELAVL4 RAPGEF2 RAB11FIP3 | 4.64e-06 | 494 | 215 | 18 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | DAB2IP MYO9A LRCH1 HRAS FGD5 PLXNA1 PLXNB3 PLXNA3 MTOR DOCK7 RAPGEF2 FGD6 MMUT EPHA5 | 1.21e-05 | 335 | 215 | 14 | GO:0043087 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.83e-05 | 53 | 215 | 6 | GO:0016339 | |
| GeneOntologyBiologicalProcess | central nervous system development | DAB2IP NCKAP1 KIF1A PTCHD1 NRXN1 TPP1 RPS6KA6 PEX5 DMD DNAH5 PLXNA1 CNTN1 KRAS PLXNA3 DYNC2H1 MSI1 RUNX1 SLC1A1 MTOR DOCK7 ROBO2 ELAVL4 RAPGEF2 SCIN TNR TP53BP2 SEZ6L EPHA5 PROX1 | 2.01e-05 | 1197 | 215 | 29 | GO:0007417 |
| GeneOntologyBiologicalProcess | L-aspartate import across plasma membrane | 2.18e-05 | 6 | 215 | 3 | GO:0140009 | |
| GeneOntologyBiologicalProcess | neuron development | DAB2IP CDK16 GABRR2 NCKAP1 KIF1A MYO9A TRPC6 NRXN1 PTPRK PTPRM PTPRQ TRPV2 DMD RAB29 SLC23A2 PLXNA1 PLXNB3 CNTN1 PLXNA3 VRK1 LAMC2 RUNX1 KATNA1 SLC1A3 PBRM1 THRB MTOR DOCK7 ROBO2 ELAVL4 RAPGEF2 TNR EPHA5 | 2.19e-05 | 1463 | 215 | 33 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ILDR2 DCHS2 NEXMIF CDHR5 ITGA2 FAT1 NRXN1 PTPRM PCDH19 TMEM131L PLXNB3 CNTN1 SH2B3 PCDHB9 PCDHA3 RUNX1 CDH24 CDH22 PBRM1 MTOR FIBP ROBO2 DSG4 TNR CDH5 PCDH7 CDH18 | 2.21e-05 | 1077 | 215 | 27 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | DAB2IP EPS8 NCKAP1 KIF1A TRPC6 CDHR5 NRXN1 HRAS TRPV2 DMD RAB29 PLXNA1 PLXNB3 CNTN1 VIL1 PLXNA3 KATNA1 MTOR ROBO2 ELAVL4 RAPGEF2 TNR RAB11FIP3 | 2.72e-05 | 846 | 215 | 23 | GO:0120035 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | DAB2IP NCKAP1 KIF1A MYO9A TRPC6 NRXN1 PTPRM TRPV2 DMD SLC23A2 PLXNA1 PLXNB3 CNTN1 VIL1 PLXNA3 LAMC2 DOCK7 ROBO2 ELAVL4 RAPGEF2 TNR EPHA5 | 4.90e-05 | 819 | 215 | 22 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | DAB2IP NCKAP1 KIF1A MYO9A TRPC6 NRXN1 PTPRM TRPV2 DMD SLC23A2 PLXNA1 PLXNB3 CNTN1 VIL1 PLXNA3 LAMC2 DOCK7 ROBO2 ELAVL4 RAPGEF2 TNR EPHA5 | 5.55e-05 | 826 | 215 | 22 | GO:0048858 |
| GeneOntologyBiologicalProcess | forebrain development | DAB2IP KIF1A PTCHD1 PEX5 DNAH5 PLXNA1 KRAS PLXNA3 DYNC2H1 DOCK7 ROBO2 ELAVL4 RAPGEF2 TNR EPHA5 PROX1 | 5.81e-05 | 489 | 215 | 16 | GO:0030900 |
| GeneOntologyBiologicalProcess | olfactory nerve development | 6.02e-05 | 8 | 215 | 3 | GO:0021553 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | DAB2IP NCKAP1 KIF1A MYO9A TRPC6 NRXN1 PTPRM TRPV2 DMD SLC23A2 PLXNA1 PLXNB3 CNTN1 PLXNA3 LAMC2 DOCK7 ROBO2 ELAVL4 RAPGEF2 TNR EPHA5 | 1.05e-04 | 802 | 215 | 21 | GO:0048812 |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 1.08e-04 | 2 | 215 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | negative regulation of GTPase activity | 1.67e-04 | 27 | 215 | 4 | GO:0034260 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 1.70e-04 | 50 | 215 | 5 | GO:0044331 | |
| GeneOntologyBiologicalProcess | L-aspartate transmembrane transport | 1.73e-04 | 11 | 215 | 3 | GO:0070778 | |
| GeneOntologyBiologicalProcess | neuron projection development | DAB2IP CDK16 NCKAP1 KIF1A MYO9A TRPC6 NRXN1 PTPRK PTPRM TRPV2 DMD RAB29 SLC23A2 PLXNA1 PLXNB3 CNTN1 PLXNA3 VRK1 LAMC2 KATNA1 PBRM1 MTOR DOCK7 ROBO2 ELAVL4 RAPGEF2 TNR EPHA5 | 1.75e-04 | 1285 | 215 | 28 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | DAB2IP EPS8 KIF1A MYO9A TRPC6 BRWD3 BRCA1 PTPRM TRPV2 FGD5 SLC23A2 PLXNA1 PLXNB3 VIL1 PLXNA3 FLT1 NRAS SH2B3 RUNX1 CREB3L1 ROBO2 RAPGEF2 TNR FGD6 CDH5 | 1.85e-04 | 1090 | 215 | 25 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | DAB2IP KIF1A TRPC6 NRXN1 TRPV2 DMD RAB29 PLXNA1 PLXNB3 CNTN1 PLXNA3 KATNA1 MTOR ROBO2 ELAVL4 RAPGEF2 TNR | 2.46e-04 | 612 | 215 | 17 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of cell shape | 2.70e-04 | 159 | 215 | 8 | GO:0008360 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | EPS8 RIN3 TRPC6 BRCA1 NRXN1 SACS PEX5 RAB29 PLXNB3 VIL1 PLXNA3 PON1 APOC3 KATNA1 RLF MTOR ROBO2 RAPGEF2 SCIN TNR CDH5 | 2.89e-04 | 864 | 215 | 21 | GO:0051129 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRR2 KIF1B PTCHD1 NRXN1 HRAS DMD BSN KRAS CACNA1C PCDHB9 GRIK4 USP46 SLC1A1 SLC1A3 SLC1A6 MTOR RIMS4 STON2 RAPGEF2 TNR MCTP2 ALG13 | 3.05e-04 | 931 | 215 | 22 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRR2 KIF1B PTCHD1 NRXN1 HRAS DMD BSN KRAS CACNA1C PCDHB9 GRIK4 USP46 SLC1A1 SLC1A3 SLC1A6 MTOR RIMS4 STON2 RAPGEF2 TNR MCTP2 ALG13 | 3.05e-04 | 931 | 215 | 22 | GO:0007268 |
| GeneOntologyBiologicalProcess | L-ascorbic acid transmembrane transport | 3.22e-04 | 3 | 215 | 2 | GO:0015882 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRR2 KIF1B PTCHD1 NRXN1 HRAS DMD BSN KRAS CACNA1C PCDHB9 GRIK4 USP46 SLC1A1 SLC1A3 SLC1A6 MTOR RIMS4 STON2 RAPGEF2 TNR MCTP2 ALG13 | 3.42e-04 | 939 | 215 | 22 | GO:0099537 |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 3.59e-04 | 126 | 215 | 7 | GO:0033555 | |
| GeneOntologyBiologicalProcess | very-low-density lipoprotein particle assembly | 3.73e-04 | 14 | 215 | 3 | GO:0034379 | |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 3.95e-04 | 128 | 215 | 7 | GO:0007265 | |
| GeneOntologyCellularComponent | axon | DAB2IP GABRR2 EPS8 RIN3 KIF1A MYO9A KIF1B ITGA2 NRXN1 PTPRK SACS TRPV2 DMD BSN CNTN1 CACNA1C TRPA1 GRIK4 KATNA1 SLC1A1 DOCK7 ROBO2 ELAVL4 EPHA5 | 1.82e-05 | 891 | 216 | 24 | GO:0030424 |
| GeneOntologyCellularComponent | anchoring junction | ILDR2 DCHS2 EPPK1 NCKAP1 TRPC6 ITGA2 AFAP1L1 FAT1 NRXN1 PTPRK PTPRM DMD KRAS FLT1 PRIMA1 CDH24 CDH22 LAT DOCK7 DSG4 RAPGEF2 SCIN CDH5 CDH18 EPHA5 | 2.79e-05 | 976 | 216 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | COP9 signalosome | 4.28e-05 | 38 | 216 | 5 | GO:0008180 | |
| GeneOntologyCellularComponent | glutamatergic synapse | EPS8 MYO9A SH3GLB2 DAPK1 CHD4 NRXN1 HRAS BSN PLXNA1 CNTN1 CACNA1C GRIK4 USP46 SLC1A6 SACM1L MTOR RIMS4 ROBO2 ELAVL4 TNR SEZ6L | 1.20e-04 | 817 | 216 | 21 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | GABRR2 EPS8 PDE4B NCKAP1 KIF1A MYO9A KIF1B SH3GLB2 DAPK1 DMD BSN CNTN1 CACNA1C GRIK4 SLC1A1 SLC1A3 SLC1A6 MTOR ARFGAP1 ROBO2 ELAVL4 RAPGEF2 SEZ6L RAB11FIP3 | 1.46e-04 | 1018 | 216 | 24 | GO:0098794 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 2.88e-04 | 13 | 216 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | catenin complex | 3.18e-04 | 32 | 216 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | cell-cell junction | ILDR2 DCHS2 EPPK1 TRPC6 FAT1 NRXN1 PTPRK PTPRM CDH24 CDH22 LAT DSG4 RAPGEF2 CDH5 CDH18 EPHA5 | 4.51e-04 | 591 | 216 | 16 | GO:0005911 |
| GeneOntologyCellularComponent | cell body | DAB2IP RIN3 KIF1A NRXN1 PTPRK TRPV2 DMD BSN CNGA2 CACNA1C TCP1 APOB GRIK4 KATNA1 SLC1A1 SLC1A3 MTOR ELAVL4 RAPGEF2 SEZ6L EPHA5 | 6.66e-04 | 929 | 216 | 21 | GO:0044297 |
| GeneOntologyCellularComponent | lamellipodium | 6.74e-04 | 230 | 216 | 9 | GO:0030027 | |
| GeneOntologyCellularComponent | receptor complex | GABRR2 EPS8 ITGA2 PTPRQ PLXNA1 PLXNB3 PLXNA3 FLT1 DIABLO GRIK4 NT5DC3 SACM1L TRBV13 MTTP EPHA5 | 1.09e-03 | 581 | 216 | 15 | GO:0043235 |
| GeneOntologyCellularComponent | neuronal cell body | DAB2IP RIN3 KIF1A NRXN1 PTPRK DMD BSN CNGA2 CACNA1C APOB GRIK4 KATNA1 SLC1A1 SLC1A3 MTOR ELAVL4 RAPGEF2 SEZ6L EPHA5 | 1.11e-03 | 835 | 216 | 19 | GO:0043025 |
| HumanPheno | Linear nevus sebaceous | 4.49e-06 | 3 | 85 | 3 | HP:0010817 | |
| Domain | Cadherin_CS | DCHS2 CDHR5 FAT1 PCDH19 PCDHB9 PCDHA3 CDH24 CDH22 DSG4 CDH5 PCDH7 CDH18 | 3.05e-09 | 109 | 207 | 12 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 CDHR5 FAT1 PCDH19 PCDHB9 PCDHA3 CDH24 CDH22 DSG4 CDH5 PCDH7 CDH18 | 4.63e-09 | 113 | 207 | 12 | PS00232 |
| Domain | CADHERIN_2 | DCHS2 CDHR5 FAT1 PCDH19 PCDHB9 PCDHA3 CDH24 CDH22 DSG4 CDH5 PCDH7 CDH18 | 5.12e-09 | 114 | 207 | 12 | PS50268 |
| Domain | - | DCHS2 CDHR5 FAT1 PCDH19 PCDHB9 PCDHA3 CDH24 CDH22 DSG4 CDH5 PCDH7 CDH18 | 5.12e-09 | 114 | 207 | 12 | 2.60.40.60 |
| Domain | CA | DCHS2 CDHR5 FAT1 PCDH19 PCDHB9 PCDHA3 CDH24 CDH22 DSG4 CDH5 PCDH7 CDH18 | 5.66e-09 | 115 | 207 | 12 | SM00112 |
| Domain | Cadherin-like | DCHS2 CDHR5 FAT1 PCDH19 PCDHB9 PCDHA3 CDH24 CDH22 DSG4 CDH5 PCDH7 CDH18 | 6.26e-09 | 116 | 207 | 12 | IPR015919 |
| Domain | Cadherin | DCHS2 CDHR5 FAT1 PCDH19 PCDHB9 PCDHA3 CDH24 CDH22 DSG4 CDH5 PCDH7 CDH18 | 7.61e-09 | 118 | 207 | 12 | IPR002126 |
| Domain | Cadherin | DCHS2 FAT1 PCDH19 PCDHB9 PCDHA3 CDH24 CDH22 DSG4 CDH5 PCDH7 CDH18 | 5.15e-08 | 113 | 207 | 11 | PF00028 |
| Domain | Vitellinogen_superhlx | 1.34e-06 | 3 | 207 | 3 | IPR011030 | |
| Domain | Cadherin_C | 7.07e-06 | 25 | 207 | 5 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 7.07e-06 | 25 | 207 | 5 | IPR000233 | |
| Domain | Catenin_binding_dom | 1.52e-05 | 29 | 207 | 5 | IPR027397 | |
| Domain | - | 1.52e-05 | 29 | 207 | 5 | 4.10.900.10 | |
| Domain | P-loop_NTPase | MYH3 MYH6 KIF1A MYO9A KIF1B DAPK1 CHD4 MYO5C DHX8 MDN1 HRAS HELZ RAB29 DNAH5 RAB5C KRAS DDX31 NRAS DYNC2H1 KATNA1 KIF7 SLFN13 CHTF18 SLFN11 | 2.46e-05 | 848 | 207 | 24 | IPR027417 |
| Domain | NA_DICARBOXYL_SYMP_1 | 4.54e-05 | 7 | 207 | 3 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 4.54e-05 | 7 | 207 | 3 | PS00714 | |
| Domain | SDF | 4.54e-05 | 7 | 207 | 3 | PF00375 | |
| Domain | - | 4.54e-05 | 7 | 207 | 3 | 1.10.3860.10 | |
| Domain | Na-dicarboxylate_symporter | 4.54e-05 | 7 | 207 | 3 | IPR001991 | |
| Domain | Na-dicarboxylate_symporter_CS | 4.54e-05 | 7 | 207 | 3 | IPR018107 | |
| Domain | Plexin_cytopl | 1.07e-04 | 9 | 207 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.07e-04 | 9 | 207 | 3 | IPR013548 | |
| Domain | Plexin | 1.07e-04 | 9 | 207 | 3 | IPR031148 | |
| Domain | Vitellinogen_b-sht_N | 1.22e-04 | 2 | 207 | 2 | IPR015816 | |
| Domain | Lipid_transp_b-sht_shell | 1.22e-04 | 2 | 207 | 2 | IPR015819 | |
| Domain | - | 1.22e-04 | 2 | 207 | 2 | 2.30.230.10 | |
| Domain | VITELLOGENIN | 1.22e-04 | 2 | 207 | 2 | PS51211 | |
| Domain | LPD_N | 1.22e-04 | 2 | 207 | 2 | SM00638 | |
| Domain | Lipid_transpt_N | 1.22e-04 | 2 | 207 | 2 | IPR001747 | |
| Domain | - | 1.22e-04 | 2 | 207 | 2 | 1.25.10.20 | |
| Domain | Vitellogenin_N | 1.22e-04 | 2 | 207 | 2 | PF01347 | |
| Domain | Ion_trans_dom | 2.81e-04 | 114 | 207 | 7 | IPR005821 | |
| Domain | Ion_trans | 2.81e-04 | 114 | 207 | 7 | PF00520 | |
| Domain | DUF2075 | 3.64e-04 | 3 | 207 | 2 | PF09848 | |
| Domain | DUF2075 | 3.64e-04 | 3 | 207 | 2 | IPR018647 | |
| Domain | Gelsolin | 4.46e-04 | 14 | 207 | 3 | PF00626 | |
| Domain | Gelsolin-like_dom | 4.46e-04 | 14 | 207 | 3 | IPR007123 | |
| Domain | ATPase_dyneun-rel_AAA | 4.46e-04 | 14 | 207 | 3 | IPR011704 | |
| Domain | AAA_5 | 4.46e-04 | 14 | 207 | 3 | PF07728 | |
| Domain | Myosin_N | 5.53e-04 | 15 | 207 | 3 | PF02736 | |
| Domain | Myosin_N | 5.53e-04 | 15 | 207 | 3 | IPR004009 | |
| Domain | Kinesin-like_KIF1-typ | 7.23e-04 | 4 | 207 | 2 | IPR022140 | |
| Domain | Pecanex_C | 7.23e-04 | 4 | 207 | 2 | PF05041 | |
| Domain | KIF1B | 7.23e-04 | 4 | 207 | 2 | PF12423 | |
| Domain | Gal_mutarotase_N | 7.23e-04 | 4 | 207 | 2 | IPR031727 | |
| Domain | NtCtMGAM_N | 7.23e-04 | 4 | 207 | 2 | PF16863 | |
| Domain | Pecanex | 7.23e-04 | 4 | 207 | 2 | IPR007735 | |
| Domain | Myosin_head_motor_dom | 8.05e-04 | 38 | 207 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 8.05e-04 | 38 | 207 | 4 | PS51456 | |
| Domain | Myosin_head | 8.05e-04 | 38 | 207 | 4 | PF00063 | |
| Domain | MYSc | 8.05e-04 | 38 | 207 | 4 | SM00242 | |
| Domain | FN3 | 1.09e-03 | 185 | 207 | 8 | SM00060 | |
| Domain | Myosin-like_IQ_dom | 1.14e-03 | 19 | 207 | 3 | IPR027401 | |
| Domain | - | 1.14e-03 | 19 | 207 | 3 | 4.10.270.10 | |
| Domain | RNase_CAF1 | 1.20e-03 | 5 | 207 | 2 | IPR006941 | |
| Domain | CAF1 | 1.20e-03 | 5 | 207 | 2 | PF04857 | |
| Domain | Kinesin_assoc | 1.78e-03 | 6 | 207 | 2 | PF16183 | |
| Domain | Glyco_hydro_31_AS | 1.78e-03 | 6 | 207 | 2 | IPR030458 | |
| Domain | Kinesin-like | 1.78e-03 | 6 | 207 | 2 | IPR022164 | |
| Domain | Kinesin_assoc | 1.78e-03 | 6 | 207 | 2 | IPR032405 | |
| Domain | DUF3694 | 1.78e-03 | 6 | 207 | 2 | PF12473 | |
| Domain | IQ | 2.06e-03 | 81 | 207 | 5 | SM00015 | |
| Domain | fn3 | 2.23e-03 | 162 | 207 | 7 | PF00041 | |
| Domain | - | 2.29e-03 | 24 | 207 | 3 | 3.40.20.10 | |
| Domain | ADF-H/Gelsolin-like_dom | 2.29e-03 | 24 | 207 | 3 | IPR029006 | |
| Domain | FN3_dom | 2.35e-03 | 209 | 207 | 8 | IPR003961 | |
| Domain | Glyco_hydro_31 | 2.47e-03 | 7 | 207 | 2 | IPR000322 | |
| Domain | AlbA_2 | 2.47e-03 | 7 | 207 | 2 | PF04326 | |
| Domain | Glyco_hydro_31 | 2.47e-03 | 7 | 207 | 2 | PF01055 | |
| Domain | Schlafen | 2.47e-03 | 7 | 207 | 2 | IPR029684 | |
| Domain | Schlafen_AAA_dom | 2.47e-03 | 7 | 207 | 2 | IPR007421 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 2.47e-03 | 7 | 207 | 2 | PS00129 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.19e-06 | 79 | 161 | 8 | M27643 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 5.08e-06 | 11 | 161 | 4 | M27740 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.00e-05 | 121 | 161 | 9 | M39823 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 1.44e-05 | 5 | 161 | 3 | M26921 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 2.03e-05 | 15 | 161 | 4 | M47475 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | WWOX NCKAP1 CHD4 ITGA2 PTPRK HRAS GRAPL KRAS RANBP10 FLT1 COL11A1 SH2B3 MTOR DOCK7 CDH5 GRAP | 2.37e-05 | 418 | 161 | 16 | MM15587 |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 2.85e-05 | 6 | 161 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 2.85e-05 | 6 | 161 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 2.85e-05 | 6 | 161 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 2.85e-05 | 6 | 161 | 3 | M47932 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 3.35e-05 | 33 | 161 | 5 | M39532 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 4.43e-05 | 18 | 161 | 4 | M39737 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 4.53e-05 | 57 | 161 | 6 | M19888 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 4.95e-05 | 7 | 161 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 4.95e-05 | 7 | 161 | 3 | M19489 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 5.92e-05 | 37 | 161 | 5 | MM14564 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 7.85e-05 | 8 | 161 | 3 | M27919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 7.85e-05 | 8 | 161 | 3 | M47935 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 8.43e-05 | 21 | 161 | 4 | M47792 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.13e-04 | 67 | 161 | 6 | MM15345 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.15e-04 | 129 | 161 | 8 | M5539 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 1.17e-04 | 9 | 161 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 1.17e-04 | 9 | 161 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 1.17e-04 | 9 | 161 | 3 | M27904 | |
| Pathway | KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 23 | 161 | 4 | M47799 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 1.24e-04 | 43 | 161 | 5 | M508 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | WWOX NCKAP1 CHD4 ITGA2 PTPRK HRAS KRAS RANBP10 FLT1 COL11A1 NRAS SH2B3 LAMC2 MTOR DOCK7 CDH5 GRAP | 1.24e-04 | 532 | 161 | 17 | M27870 |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 1.38e-04 | 44 | 161 | 5 | M175 | |
| Pathway | REACTOME_CHYLOMICRON_ASSEMBLY | 1.65e-04 | 10 | 161 | 3 | M27838 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 1.65e-04 | 10 | 161 | 3 | MM15488 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 1.72e-04 | 25 | 161 | 4 | M27865 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | ITGA2 HRAS KRAS FLT1 COL11A1 NRAS LAMC2 HIF3A CREB3L1 MTOR TNR PIK3R5 | 1.82e-04 | 302 | 161 | 12 | M39719 |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 1.97e-04 | 74 | 161 | 6 | M39857 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.10e-04 | 106 | 161 | 7 | M27077 | |
| Pathway | PID_PI3KCI_PATHWAY | 2.10e-04 | 48 | 161 | 5 | M141 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 2.26e-04 | 11 | 161 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.26e-04 | 11 | 161 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.26e-04 | 11 | 161 | 3 | M47371 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 2.26e-04 | 11 | 161 | 3 | M27911 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 2.26e-04 | 11 | 161 | 3 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 2.26e-04 | 11 | 161 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 2.26e-04 | 11 | 161 | 3 | M47432 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 2.55e-04 | 50 | 161 | 5 | M39822 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 2.71e-04 | 28 | 161 | 4 | M837 | |
| Pathway | REACTOME_TRP_CHANNELS | 2.71e-04 | 28 | 161 | 4 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 2.71e-04 | 28 | 161 | 4 | M27241 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.98e-04 | 12 | 161 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 2.98e-04 | 12 | 161 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 2.98e-04 | 12 | 161 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 2.98e-04 | 12 | 161 | 3 | M39408 | |
| Pathway | REACTOME_DAP12_SIGNALING | 3.12e-04 | 29 | 161 | 4 | M27171 | |
| Pathway | WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS | 3.12e-04 | 29 | 161 | 4 | M39516 | |
| Pathway | PID_RAS_PATHWAY | 3.56e-04 | 30 | 161 | 4 | M269 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | ITGA2 HRAS KRAS FLT1 COL11A1 NRAS LAMC2 HIF3A CREB3L1 MTOR TNR PIK3R5 | 3.66e-04 | 326 | 161 | 12 | MM15917 |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 3.84e-04 | 13 | 161 | 3 | M47594 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 3.84e-04 | 13 | 161 | 3 | M1441 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 4.59e-04 | 32 | 161 | 4 | M39445 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.85e-04 | 14 | 161 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 4.85e-04 | 14 | 161 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 4.85e-04 | 14 | 161 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 4.85e-04 | 14 | 161 | 3 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 4.85e-04 | 14 | 161 | 3 | M47378 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 4.85e-04 | 14 | 161 | 3 | M569 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 4.85e-04 | 14 | 161 | 3 | M27908 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 4.85e-04 | 14 | 161 | 3 | M27734 | |
| Pathway | PID_TCR_RAS_PATHWAY | 4.85e-04 | 14 | 161 | 3 | M134 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 4.85e-04 | 14 | 161 | 3 | M47488 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 4.85e-04 | 14 | 161 | 3 | M719 | |
| Pathway | KEGG_PROSTATE_CANCER | 5.38e-04 | 89 | 161 | 6 | M13191 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.56e-04 | 59 | 161 | 5 | M27218 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 5.82e-04 | 34 | 161 | 4 | M27842 | |
| Pathway | WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS | 5.82e-04 | 34 | 161 | 4 | M48081 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 6.01e-04 | 15 | 161 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 7.34e-04 | 16 | 161 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 7.34e-04 | 16 | 161 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 7.34e-04 | 16 | 161 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 7.34e-04 | 16 | 161 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 7.34e-04 | 16 | 161 | 3 | M47801 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 7.34e-04 | 16 | 161 | 3 | M562 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 7.34e-04 | 16 | 161 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 7.34e-04 | 16 | 161 | 3 | M47682 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 7.34e-04 | 16 | 161 | 3 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 7.34e-04 | 16 | 161 | 3 | M47483 | |
| Pubmed | DAB2IP PDE4B CAND1 NCKAP1 MCC DAPK1 CHD4 MDN1 SBF1 NRXN1 UBR5 HRAS PEX5 HERC2 BSN CNTN1 KRAS RANBP10 SLC1A3 KIF7 PBRM1 SEC24C MTOR SPHKAP STON2 DOCK7 ELAVL4 RAPGEF2 TNR TP53BP2 PROX1 | 9.37e-14 | 963 | 218 | 31 | 28671696 | |
| Pubmed | DAB2IP MBTPS1 NCKAP1 PPRC1 TMEM94 SPEG KIF1B ZBTB43 UBR5 PCDH19 MCM3AP SLC23A2 PLXNB3 ZYG11B SACM1L SEC24C SPHKAP DOCK7 SEZ6L | 1.54e-11 | 407 | 218 | 19 | 12693553 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DAB2IP EPS8 TMEM94 DAPK1 CDHR5 ITGA2 H3C15 FAT1 PTPRM HRAS PLXNA1 KRAS NRAS SMPD4 APOB SLC1A3 MTOR STON2 DOCK7 FGD6 PCDH7 | 1.00e-10 | 569 | 218 | 21 | 30639242 |
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 2.23e-08 | 6 | 218 | 4 | 29615452 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 5.01e-08 | 153 | 218 | 10 | 26365490 | |
| Pubmed | DAB2IP CDK16 EPS8 WWOX TMEM94 ITGA2 LRCH1 SBF1 PTPRM GFOD2 PCDH19 DMD USP46 ROBO2 PCDH7 | 8.20e-08 | 421 | 218 | 15 | 36976175 | |
| Pubmed | 1.35e-07 | 129 | 218 | 9 | 23022380 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | EPS8 MBTPS1 RIN3 MCC CNOT8 SBF1 PTPRK MCM3AP CNOT7 HRAS RPS6KA6 PEX5 COPS6 CNTN1 KRAS PLXNA3 DIABLO MTOR ARFGAP1 DOCK7 FIBP ROBO2 EMD TP53BP2 | 1.95e-07 | 1124 | 218 | 24 | 21900206 |
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 2.43e-07 | 3 | 218 | 3 | 28116986 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 2.43e-07 | 3 | 218 | 3 | 19101897 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 33620658 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 2.43e-07 | 3 | 218 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 2.43e-07 | 3 | 218 | 3 | 7776260 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 25788415 | ||
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 2.43e-07 | 3 | 218 | 3 | 26799184 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 2.43e-07 | 3 | 218 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 2.43e-07 | 3 | 218 | 3 | 23240926 | |
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 2.43e-07 | 3 | 218 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 2.43e-07 | 3 | 218 | 3 | 17712732 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 24222113 | ||
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 2.43e-07 | 3 | 218 | 3 | 22945650 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 19303097 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 2.43e-07 | 3 | 218 | 3 | 20150643 | |
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 2.43e-07 | 3 | 218 | 3 | 9334313 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 2.43e-07 | 3 | 218 | 3 | 37013448 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 25977330 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 2.43e-07 | 3 | 218 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 2.43e-07 | 3 | 218 | 3 | 26253102 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 16573741 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 2.43e-07 | 3 | 218 | 3 | 20090846 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 21737741 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 17727989 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 17943694 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 2.43e-07 | 3 | 218 | 3 | 16761621 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 17221839 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 20971740 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 27119512 | ||
| Pubmed | ILDR2 EPS8 MYH6 CAND1 NCKAP1 MYO9A KIF1B DAPK1 ALDH1L1 ITGA2 SBF1 SACS DMD BSN RAB5C CNTN1 TCP1 NT5DC3 SLC1A3 SACM1L SEC24C STON2 DOCK7 RAPGEF2 TNR TP53BP2 ATP5F1C | 3.72e-07 | 1431 | 218 | 27 | 37142655 | |
| Pubmed | CAND1 KIF1B CHD4 FAT1 BRCA1 UBR5 PEX5 TDRKH TCP1 APOB ESF1 SEC24C SLFN13 ARFGAP1 DOCK7 EMD RAPGEF2 PCDH7 ATP5F1C | 5.38e-07 | 777 | 218 | 19 | 35844135 | |
| Pubmed | EPPK1 NCKAP1 KIF1A CHD4 DHX8 MDN1 SBF1 UBR5 MCM3AP HELZ HERC2 DDX31 ESF1 PBRM1 SEC24C MTOR DOCK7 | 9.33e-07 | 653 | 218 | 17 | 22586326 | |
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 9379843 | ||
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 10085069 | ||
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 38849523 | ||
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 9674433 | ||
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 9.67e-07 | 4 | 218 | 3 | 28117393 | |
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 22424243 | ||
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 9.67e-07 | 4 | 218 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 9.67e-07 | 4 | 218 | 3 | 29502968 | |
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 21283084 | ||
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 9.67e-07 | 4 | 218 | 3 | 7972015 | |
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 10490827 | ||
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 9.67e-07 | 4 | 218 | 3 | 25999467 | |
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 34948093 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 9.67e-07 | 4 | 218 | 3 | 20080631 | |
| Pubmed | CDK16 EPS8 NCKAP1 KIF1B SH3GLB2 LRCH1 UBR5 HELZ KIF7 DOCK7 RAPGEF2 TP53BP2 ATP5F1C ALG13 | 1.01e-06 | 446 | 218 | 14 | 24255178 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CAND1 NCKAP1 KIF1A CHD4 DHX8 MDN1 SERPINB12 FGD5 BSN DNAH5 PLXNA1 ADGRA3 MGAM2 VRK1 TCP1 DIABLO DYNC2H1 APOB ESF1 SACM1L PBRM1 MTOR DOCK7 MPHOSPH8 EMD ATP5F1C | 1.16e-06 | 1425 | 218 | 26 | 30948266 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DAB2IP CAND1 NCKAP1 SACS UBR5 SLC1A3 MTOR RAPGEF2 TNR PCDH7 TP53BP2 | 1.84e-06 | 281 | 218 | 11 | 28706196 |
| Pubmed | DCHS2 CAND1 LARP6 KIF1A PPRC1 KIF1B ZBTB43 SH3GLB2 CHD4 BRWD3 CNOT8 NAA25 PTPRK SACS TPP1 STAMBPL1 HERC2 PLXNB3 FOXRED1 CXXC5 RUNX1 FIBP RAPGEF2 SEZ6L | 2.07e-06 | 1285 | 218 | 24 | 35914814 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 CAND1 CHD4 H3C15 MYO5C DHX8 MDN1 SACS UBR5 SERPINB12 PEX5 HERC2 RAB5C TCP1 KIF7 PBRM1 SEC24C DOCK7 EMD SCIN ATP5F1C | 2.23e-06 | 1024 | 218 | 21 | 24711643 |
| Pubmed | MCC CHD4 BRWD3 ZBTB7A ZNF469 FAT1 BRCA1 UBR5 PCDH19 MCM3AP PEX5 HELZ TDRKH MSI1 KIF7 PBRM1 FIBP SLFN11 RAPGEF2 SEZ6L PROX1 ALG13 | 2.40e-06 | 1116 | 218 | 22 | 31753913 | |
| Pubmed | 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. | 2.41e-06 | 5 | 218 | 3 | 15194687 | |
| Pubmed | 2.41e-06 | 5 | 218 | 3 | 22982107 | ||
| Pubmed | 2.41e-06 | 5 | 218 | 3 | 17540175 | ||
| Pubmed | 2.41e-06 | 5 | 218 | 3 | 9069260 | ||
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 2.41e-06 | 5 | 218 | 3 | 34535655 | |
| Pubmed | 2.41e-06 | 5 | 218 | 3 | 7809086 | ||
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 2.41e-06 | 5 | 218 | 3 | 24746824 | |
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 2.41e-06 | 5 | 218 | 3 | 15558479 | |
| Pubmed | 2.41e-06 | 5 | 218 | 3 | 9129177 | ||
| Pubmed | EPS8 CAND1 NCKAP1 PCNX3 KIF1A H3C15 CNOT8 DHX8 ZGPAT ZBTB7A MDN1 BRCA1 SBF1 TPP1 CNOT7 HELZ HERC2 RAB5C TDRKH DDX31 NRAS CXXC5 ESF1 PBRM1 MPHOSPH8 ATP5F1C | 2.86e-06 | 1497 | 218 | 26 | 31527615 | |
| Pubmed | 3.35e-06 | 17 | 218 | 4 | 11683995 | ||
| Pubmed | DAB2IP EPPK1 NCKAP1 MYO9A LRCH1 SBF1 UBR5 HERC2 TCP1 SLC1A3 ELAVL4 RAPGEF2 TNR | 3.74e-06 | 430 | 218 | 13 | 32581705 | |
| Pubmed | 4.43e-06 | 147 | 218 | 8 | 29576527 | ||
| Pubmed | DAB2IP MBTPS1 NCKAP1 CFB PTPRM HERC2 CACNA1C FLT1 SH2B3 SLFN13 RAPGEF2 CDH5 | 4.50e-06 | 371 | 218 | 12 | 15747579 | |
| Pubmed | 4.79e-06 | 6 | 218 | 3 | 9753431 | ||
| Pubmed | Lack of replication of genetic associations with human longevity. | 4.79e-06 | 6 | 218 | 3 | 18034366 | |
| Pubmed | 4.79e-06 | 6 | 218 | 3 | 21072204 | ||
| Pubmed | 4.79e-06 | 6 | 218 | 3 | 10882715 | ||
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 4.79e-06 | 6 | 218 | 3 | 31337872 | |
| Pubmed | 5.41e-06 | 19 | 218 | 4 | 25367360 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP RIN3 EPPK1 PCNX3 PPRC1 TMEM94 SPEG FANCA PCNX2 ZGPAT FAT1 MDN1 SBF1 MCM3AP HERC2 PLXNA1 PLXNA3 RANBP10 SH2B3 MTOR RAB11FIP3 | 7.19e-06 | 1105 | 218 | 21 | 35748872 |
| Pubmed | 8.22e-06 | 44 | 218 | 5 | 19322198 | ||
| Pubmed | 8.27e-06 | 21 | 218 | 4 | 25369838 | ||
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 20526288 | ||
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 20012784 | ||
| Pubmed | Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | 8.35e-06 | 7 | 218 | 3 | 35904492 | |
| Pubmed | SmgGDS displays differential binding and exchange activity towards different Ras isoforms. | 8.35e-06 | 7 | 218 | 3 | 11948427 | |
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 20860430 | ||
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 22199277 | ||
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 18701070 | ||
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 19487299 | ||
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 20179099 | ||
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 12691171 | ||
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 9690470 | ||
| Pubmed | 9.05e-06 | 162 | 218 | 8 | 15174051 | ||
| Interaction | CCDC8 interactions | MAGEA10 EPPK1 CAND1 CHD4 MYO5C MDN1 SACS UBR5 SERPINB12 PEX5 HERC2 RAB5C KRAS TDRKH TCP1 APOB KIF7 ANKRA2 DOCK7 EMD SCIN CDH5 ATP5F1C | 6.04e-07 | 656 | 215 | 23 | int:CCDC8 |
| Interaction | SLC1A4 interactions | 6.59e-07 | 30 | 215 | 6 | int:SLC1A4 | |
| Interaction | TRPV2 interactions | 2.52e-06 | 10 | 215 | 4 | int:TRPV2 | |
| Interaction | SOS1 interactions | 4.62e-06 | 117 | 215 | 9 | int:SOS1 | |
| Interaction | NOTCH1 interactions | CAND1 CHD4 LRCH1 DHX8 FANCA MDN1 HRAS RAB5C CNTN1 KRAS RANBP10 NRAS RUNX1 PBRM1 SLFN11 | 4.81e-06 | 345 | 215 | 15 | int:NOTCH1 |
| Interaction | JAM3 interactions | 1.79e-05 | 31 | 215 | 5 | int:JAM3 | |
| Interaction | HEPH interactions | 2.34e-05 | 6 | 215 | 3 | int:HEPH | |
| Interaction | SCARB1 interactions | 2.71e-05 | 112 | 215 | 8 | int:SCARB1 | |
| Interaction | EPHA2 interactions | DAB2IP CDK16 EPS8 WWOX TMEM94 ITGA2 LRCH1 SBF1 PTPRM GFOD2 PCDH19 HRAS DMD RAB5C KRAS NRAS USP46 ROBO2 CDH5 PCDH7 EPHA5 | 3.07e-05 | 719 | 215 | 21 | int:EPHA2 |
| Interaction | SEMA5A interactions | 4.06e-05 | 7 | 215 | 3 | int:SEMA5A | |
| Interaction | CCT8L2 interactions | 4.90e-05 | 157 | 215 | 9 | int:CCT8L2 | |
| GeneFamily | CD molecules|Type II classical cadherins | 4.70e-06 | 13 | 167 | 4 | 1186 | |
| GeneFamily | Plexins | 6.24e-05 | 9 | 167 | 3 | 683 | |
| GeneFamily | Transient receptor potential cation channels | 1.21e-04 | 28 | 167 | 4 | 249 | |
| GeneFamily | Cadherin related | 4.79e-04 | 17 | 167 | 3 | 24 | |
| GeneFamily | Fibronectin type III domain containing | 7.23e-04 | 160 | 167 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.50e-04 | 161 | 167 | 7 | 593 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 9.11e-04 | 21 | 167 | 3 | 813 | |
| GeneFamily | Schlafen family | 1.73e-03 | 7 | 167 | 2 | 1110 | |
| GeneFamily | Ankyrin repeat domain containing | 1.87e-03 | 242 | 167 | 8 | 403 | |
| GeneFamily | Gelsolin/villins | 2.29e-03 | 8 | 167 | 2 | 950 | |
| GeneFamily | RAS type GTPase family | 2.88e-03 | 31 | 167 | 3 | 389 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.07e-03 | 206 | 167 | 7 | 682 | |
| GeneFamily | CCR4-NOT transcription complex | 4.42e-03 | 11 | 167 | 2 | 1023 | |
| GeneFamily | Non-clustered protocadherins | 5.27e-03 | 12 | 167 | 2 | 21 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KIF1A SPEG ZBTB43 NLN MDN1 NRXN1 PTPRK PCDH19 ANKRD18A BSN PLXNA1 CNTN1 PLXNA3 CACNA1C COL11A1 KBTBD6 LAMC2 ZYG11B NT5DC3 CDH22 ROBO2 ELAVL4 SCIN PCDH7 SEZ6L ARMH4 | 1.77e-06 | 1106 | 217 | 26 | M39071 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPS8 CAND1 NCKAP1 DAPK1 FAT1 MDN1 BRCA1 PTPRK PTPRM SACS UBR5 TMEM131L HELZ DMD SLC23A2 ADGRA3 NPAT VRK1 RUNX1 RLF RAPGEF2 TP53BP2 | 2.85e-06 | 856 | 217 | 22 | M4500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT1 NRXN1 PTPRQ DMD DNAH5 CNTN1 MGAM COL11A1 APOB ELAVL4 EPHA5 | 1.86e-09 | 184 | 217 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT1 NRXN1 PTPRQ DMD DNAH5 CNTN1 MGAM COL11A1 APOB ELAVL4 EPHA5 | 1.86e-09 | 184 | 217 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT1 NRXN1 PTPRQ DMD DNAH5 CNTN1 MGAM COL11A1 APOB ELAVL4 EPHA5 | 1.86e-09 | 184 | 217 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | CD109 MCC LRCH1 AFAP1L1 PTPRK PTPRM GRAPL FGD5 FLT1 HIF3A CDH5 | 3.80e-09 | 197 | 217 | 11 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CDHR5 CES2 VIL1 MGAM SLC39A4 APOB APOC3 SLC1A1 MTTP SCIN SDCBP2 | 4.01e-09 | 198 | 217 | 11 | 8fac96132663f54566136ef54b53684d31dfde32 |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CDHR5 CES2 VIL1 MGAM SLC39A4 APOB APOC3 SLC1A1 MTTP SCIN SDCBP2 | 4.01e-09 | 198 | 217 | 11 | c48b3f026b16d48b8eca9f74dc1e3f3f39a89322 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | DAPK1 SCN7A CNTN1 CACNA1C GRIK4 SLC1A3 THRB SPHKAP ROBO2 PCDH7 | 4.86e-08 | 197 | 217 | 10 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.34e-08 | 199 | 217 | 10 | 0181c13379f869be47804cdb11bbdabcd30b9b23 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.34e-08 | 199 | 217 | 10 | ee981046217e8759610eb58a670d98f32cd83abc | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.54e-08 | 74 | 217 | 7 | ef4c9eafc794c7d50aef28b37d21b52d3c511499 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.54e-08 | 74 | 217 | 7 | 6ecbdf4186039a031410e09ecd5afa66b6d5e2dc | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.62e-08 | 158 | 217 | 9 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-07 | 170 | 217 | 9 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-07 | 174 | 217 | 9 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 2.06e-07 | 175 | 217 | 9 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 2.06e-07 | 175 | 217 | 9 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.50e-07 | 179 | 217 | 9 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.74e-07 | 181 | 217 | 9 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.87e-07 | 182 | 217 | 9 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.87e-07 | 182 | 217 | 9 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.87e-07 | 182 | 217 | 9 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 3.01e-07 | 183 | 217 | 9 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.30e-07 | 185 | 217 | 9 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-4_VIP_CHRNA2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.30e-07 | 185 | 217 | 9 | 3189e91fe26df59bd605d2b6223ceb1779daf0b8 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.30e-07 | 185 | 217 | 9 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.30e-07 | 185 | 217 | 9 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-07 | 188 | 217 | 9 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-07 | 188 | 217 | 9 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.95e-07 | 189 | 217 | 9 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.31e-07 | 191 | 217 | 9 | 44c596984c6196f6014e0e405dbe5560841e54ff | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.31e-07 | 191 | 217 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | E16.5-samps-Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.31e-07 | 191 | 217 | 9 | e7521d4d24f016d4e531cd492a7a69604f0c9e6f | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.45e-07 | 140 | 217 | 8 | b9aeb7dda7f377b580dd8a44912f300721437387 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-07 | 192 | 217 | 9 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.51e-07 | 192 | 217 | 9 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.51e-07 | 192 | 217 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.92e-07 | 194 | 217 | 9 | 44c7d4b75f3b7c9301eba20610e548a01a84ae40 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-07 | 194 | 217 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.92e-07 | 194 | 217 | 9 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.13e-07 | 195 | 217 | 9 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 5.36e-07 | 196 | 217 | 9 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-07 | 196 | 217 | 9 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-07 | 196 | 217 | 9 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-07 | 196 | 217 | 9 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.36e-07 | 196 | 217 | 9 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 5.36e-07 | 196 | 217 | 9 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-07 | 196 | 217 | 9 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.59e-07 | 197 | 217 | 9 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.59e-07 | 197 | 217 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | proximal-Epithelial-Neuroendocrine|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.83e-07 | 198 | 217 | 9 | 5dea6078488d584513c0bdbf5bba54877310b54a | |
| ToppCell | proximal-Epithelial-Neuroendocrine-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.83e-07 | 198 | 217 | 9 | 00ccf3020667cf2130bc354b441b65c0b1b0e862 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.83e-07 | 198 | 217 | 9 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.83e-07 | 198 | 217 | 9 | e3e2233c796d5e9051c8c1b66f70f406f048ed56 | |
| ToppCell | proximal-3-Epithelial-Neuroendocrine|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.83e-07 | 198 | 217 | 9 | a6bc043faf68468d46bac441cf7447c236c7bae4 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.83e-07 | 198 | 217 | 9 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.83e-07 | 198 | 217 | 9 | 2967fb2d94662997bfe932ac299c80d6f182fb48 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.83e-07 | 198 | 217 | 9 | 222a060c2c63d30da34e4b71c37aa27a048d7d09 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.83e-07 | 198 | 217 | 9 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-07 | 199 | 217 | 9 | 38432e3ccbc546dc4c1dc2fb1d8d44f8a6de9424 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-07 | 199 | 217 | 9 | 1e6ac65ce7133de4872dcd7e98e2a9e57d3d61b7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-07 | 199 | 217 | 9 | ab71b312635a2b2c98d71b60a299f44bc80a3587 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.34e-07 | 200 | 217 | 9 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-07 | 200 | 217 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.34e-07 | 200 | 217 | 9 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.17e-06 | 159 | 217 | 8 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 165 | 217 | 8 | 1703d3eb644b3c743ad3c5532b1d29ea010c79c8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-06 | 168 | 217 | 8 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 170 | 217 | 8 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 170 | 217 | 8 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 170 | 217 | 8 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 1.93e-06 | 170 | 217 | 8 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-06 | 173 | 217 | 8 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.29e-06 | 174 | 217 | 8 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.39e-06 | 175 | 217 | 8 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-06 | 176 | 217 | 8 | 6b4afd2c9268172063fe5832896bea15e862579e | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.72e-06 | 178 | 217 | 8 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.20e-06 | 182 | 217 | 8 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 182 | 217 | 8 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 3.20e-06 | 182 | 217 | 8 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.34e-06 | 183 | 217 | 8 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-06 | 184 | 217 | 8 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-06 | 185 | 217 | 8 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.76e-06 | 186 | 217 | 8 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-06 | 186 | 217 | 8 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-06 | 187 | 217 | 8 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 3.92e-06 | 187 | 217 | 8 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 3.92e-06 | 187 | 217 | 8 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | facs-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.07e-06 | 188 | 217 | 8 | dd817059e1b4225e84733559f7839cc973b7dfd6 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.07e-06 | 188 | 217 | 8 | 6ab5ce8569f896a0fe7a76b8b4a83661e5499b8c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.07e-06 | 188 | 217 | 8 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-06 | 188 | 217 | 8 | 006db2c2c44971ca9241c582bc89f258c785f5ed | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.07e-06 | 188 | 217 | 8 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.07e-06 | 188 | 217 | 8 | 20072a2a3f9ecbe727c850629f19420cf60e4bc5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.07e-06 | 188 | 217 | 8 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 4.07e-06 | 188 | 217 | 8 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-06 | 188 | 217 | 8 | d0e6fb4a3b3d79d3512b5500062ea285495ae526 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.24e-06 | 189 | 217 | 8 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.24e-06 | 189 | 217 | 8 | 1d660bceee449aebf12fc9af4c74af246837b27a | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.24e-06 | 189 | 217 | 8 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.24e-06 | 189 | 217 | 8 | 5a9c3c61998efc40a5d2042e0f568b52103734a9 | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A | RIN3 KIF1A CES2 ZBTB7A BRCA1 SBF1 PEX5 FAM118A TDRKH RUNX1 MTOR | 2.42e-06 | 196 | 212 | 11 | 5091_DN |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A | SPEG ZBTB43 ZGPAT TPP1 SLC23A2 DDX31 USP46 RUNX1 NT5DC3 FGD6 RAB11FIP3 | 2.42e-06 | 196 | 212 | 11 | 7391_DN |
| Drug | L 744832 | 3.16e-06 | 4 | 212 | 3 | ctd:C096898 | |
| Disease | Follicular thyroid carcinoma | 1.26e-08 | 5 | 211 | 4 | C0206682 | |
| Disease | Hemimegalencephaly | 3.77e-08 | 6 | 211 | 4 | C0431391 | |
| Disease | Leukemia, Myelocytic, Acute | PDE4B CEBPD DAPK1 FANCA ZBTB7A BRCA1 HRAS KRAS NRAS SH2B3 RUNX1 | 5.27e-08 | 173 | 211 | 11 | C0023467 |
| Disease | Verrucous epidermal nevus | 3.61e-07 | 3 | 211 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 3.61e-07 | 3 | 211 | 3 | C4552097 | |
| Disease | Linear nevus sebaceous syndrome | 3.61e-07 | 3 | 211 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 3.61e-07 | 3 | 211 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 3.61e-07 | 3 | 211 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 3.61e-07 | 3 | 211 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 3.61e-07 | 3 | 211 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Linear Verrucous Epidermal Nevus | 3.61e-07 | 3 | 211 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 3.61e-07 | 3 | 211 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | Organoid Nevus Phakomatosis | 3.61e-07 | 3 | 211 | 3 | C0265329 | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 3.61e-07 | 3 | 211 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Autistic Disorder | PDE4B KIF1A MCC CHD4 PTCHD1 NRXN1 SCN7A HRAS CACNA1C PON1 SLC1A3 ROBO2 | 4.45e-07 | 261 | 211 | 12 | C0004352 |
| Disease | cancer (implicated_via_orthology) | CAND1 WWOX ESRRB HRAS PIPSL RAB5C KRAS FLT1 NRAS HIF3A MTOR PROX1 | 5.89e-07 | 268 | 211 | 12 | DOID:162 (implicated_via_orthology) |
| Disease | Colorectal Carcinoma | AMACR CD109 MCC ALDH1L1 FAT1 SACS MCM3AP DMD RAB5C CNTN1 KRAS NRAS APOB ADAMTSL3 PRIMA1 CDH22 SDCBP2 CDH5 PIK3R5 | 8.16e-07 | 702 | 211 | 19 | C0009402 |
| Disease | NEVUS, EPIDERMAL (disorder) | 3.57e-06 | 5 | 211 | 3 | C0334082 | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 7.10e-06 | 6 | 211 | 3 | DOID:0050994 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 7.39e-06 | 38 | 211 | 5 | DOID:114 (implicated_via_orthology) | |
| Disease | MYELODYSPLASTIC SYNDROME | 8.64e-06 | 67 | 211 | 6 | C3463824 | |
| Disease | Juvenile Myelomonocytic Leukemia | 9.05e-06 | 19 | 211 | 4 | C0349639 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.08e-05 | 41 | 211 | 5 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.08e-05 | 41 | 211 | 5 | C0858252 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.73e-05 | 45 | 211 | 5 | DOID:3748 (is_implicated_in) | |
| Disease | urinary bladder cancer (is_implicated_in) | 1.79e-05 | 76 | 211 | 6 | DOID:11054 (is_implicated_in) | |
| Disease | Muscular Dystrophy | 1.97e-05 | 8 | 211 | 3 | C0026850 | |
| Disease | Intellectual Disability | CDK16 TMEM94 MCC BRWD3 PTCHD1 BRCA1 NRXN1 SACS TPP1 VRK1 KIF7 MTOR ALG13 | 2.24e-05 | 447 | 211 | 13 | C3714756 |
| Disease | colorectal cancer (is_implicated_in) | 2.74e-05 | 121 | 211 | 7 | DOID:9256 (is_implicated_in) | |
| Disease | diabetic retinopathy (is_implicated_in) | 2.91e-05 | 50 | 211 | 5 | DOID:8947 (is_implicated_in) | |
| Disease | RASopathy (implicated_via_orthology) | 2.93e-05 | 9 | 211 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Acute Myeloid Leukemia, M1 | 3.38e-05 | 125 | 211 | 7 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 3.38e-05 | 125 | 211 | 7 | C1879321 | |
| Disease | angina pectoris | 3.38e-05 | 125 | 211 | 7 | EFO_0003913 | |
| Disease | Bipolar Disorder | GABRR2 PDE4B NRXN1 CACNA1C PON1 GRIK4 USP46 SLC1A1 SLC1A3 SLC1A6 PBRM1 SEC24C SEZ6L | 4.37e-05 | 477 | 211 | 13 | C0005586 |
| Disease | lung small cell carcinoma (is_implicated_in) | 4.55e-05 | 28 | 211 | 4 | DOID:5409 (is_implicated_in) | |
| Disease | myocardial infarction | DAB2IP CD109 NAA25 FGD5 PAPPA2 TDRKH FLT1 DYNC2H1 APOB FGD6 ARMH4 | 4.82e-05 | 350 | 211 | 11 | EFO_0000612 |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 5.09e-05 | 2 | 211 | 2 | 614470 | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 5.09e-05 | 2 | 211 | 2 | 137550 | |
| Disease | Melanocytic nevus | 5.09e-05 | 2 | 211 | 2 | cv:C0027962 | |
| Disease | Large congenital melanocytic nevus | 5.09e-05 | 2 | 211 | 2 | cv:C1842036 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 5.09e-05 | 2 | 211 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 5.09e-05 | 2 | 211 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 5.09e-05 | 2 | 211 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 5.09e-05 | 2 | 211 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Neurotoxicity Syndromes | 5.25e-05 | 29 | 211 | 4 | C0235032 | |
| Disease | Encephalopathy, Toxic | 5.25e-05 | 29 | 211 | 4 | C0149504 | |
| Disease | Toxic Encephalitis | 5.25e-05 | 29 | 211 | 4 | C0154659 | |
| Disease | Noonan Syndrome 1 | 5.70e-05 | 11 | 211 | 3 | C4551602 | |
| Disease | beta thalassemia (is_marker_for) | 5.70e-05 | 11 | 211 | 3 | DOID:12241 (is_marker_for) | |
| Disease | Turner Syndrome, Male | 5.70e-05 | 11 | 211 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 5.70e-05 | 11 | 211 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 5.70e-05 | 11 | 211 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 8.49e-05 | 100 | 211 | 6 | C0010606 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 8.95e-05 | 63 | 211 | 5 | EFO_0001645, EFO_0004792 | |
| Disease | carcinoma (implicated_via_orthology) | 9.65e-05 | 64 | 211 | 5 | DOID:305 (implicated_via_orthology) | |
| Disease | Hyperlipoproteinemia Type IIb | 9.78e-05 | 13 | 211 | 3 | C1704417 | |
| Disease | lipoprotein measurement | 1.11e-04 | 105 | 211 | 6 | EFO_0004732 | |
| Disease | Malformations of Cortical Development | 1.24e-04 | 14 | 211 | 3 | C1955869 | |
| Disease | Cortical Dysplasia | 1.24e-04 | 14 | 211 | 3 | C0431380 | |
| Disease | Breast Carcinoma | WWOX CD109 BRCA1 HRAS FGD5 HERC2 KRAS FLT1 DYNC2H1 PBRM1 MTOR CDH5 TP53BP2 | 1.46e-04 | 538 | 211 | 13 | C0678222 |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 1.52e-04 | 3 | 211 | 2 | C1842036 | |
| Disease | Malignant neoplasm of prostate | DAB2IP MBTPS1 AMACR ZBTB7A BRCA1 PTPRK TPP1 HRAS KRAS TCP1 DIABLO PON1 RUNX1 ROBO2 | 1.53e-04 | 616 | 211 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | DAB2IP MBTPS1 AMACR ZBTB7A BRCA1 PTPRK TPP1 HRAS KRAS TCP1 DIABLO PON1 RUNX1 ROBO2 | 1.53e-04 | 616 | 211 | 14 | C0033578 |
| Disease | quinate measurement | 1.54e-04 | 15 | 211 | 3 | EFO_0021167 | |
| Disease | RASopathy | 1.54e-04 | 15 | 211 | 3 | cv:C5555857 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.58e-04 | 71 | 211 | 5 | EFO_0001645, EFO_0004791 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.58e-04 | 71 | 211 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 1.72e-04 | 39 | 211 | 4 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | Hypercholesterolemia | 1.72e-04 | 39 | 211 | 4 | C0020443 | |
| Disease | epilepsy (implicated_via_orthology) | 1.80e-04 | 163 | 211 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Hyperlipoproteinemia Type IIa | 1.88e-04 | 16 | 211 | 3 | C0745103 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.11e-04 | 118 | 211 | 6 | EFO_0001645, EFO_0004629 | |
| Disease | Schizophrenia | CDK16 PDE4B AMACR CHD4 BRCA1 NRXN1 CACNA1C PON1 GRIK4 ADAMTSL3 SLC1A1 SLC1A3 SLC1A6 PBRM1 MTOR STON2 MCTP2 | 2.24e-04 | 883 | 211 | 17 | C0036341 |
| Disease | nicotine dependence symptom count | 2.27e-04 | 285 | 211 | 9 | EFO_0009262 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 2.30e-04 | 42 | 211 | 4 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | Hemangiosarcoma | 2.72e-04 | 18 | 211 | 3 | C0018923 | |
| Disease | Hypercholesterolemia, Familial | 2.72e-04 | 18 | 211 | 3 | C0020445 | |
| Disease | Thyroid carcinoma | 2.76e-04 | 44 | 211 | 4 | C0549473 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.77e-04 | 80 | 211 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | WWOX CD109 NAA25 BRCA1 HRAS FGD5 HERC2 DMD CNGA2 KRAS FLT1 COL11A1 TCP1 DYNC2H1 MSI1 PBRM1 MTOR CDH5 TP53BP2 | 2.79e-04 | 1074 | 211 | 19 | C0006142 |
| Disease | Malignant neoplasm of salivary gland | 3.01e-04 | 45 | 211 | 4 | C0220636 | |
| Disease | Malignant neoplasm of penis | 3.02e-04 | 4 | 211 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 3.02e-04 | 4 | 211 | 2 | C0030849 | |
| Disease | BLADDER CANCER | 3.02e-04 | 4 | 211 | 2 | 109800 | |
| Disease | Epidermal nevus | 3.02e-04 | 4 | 211 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 3.02e-04 | 4 | 211 | 2 | cv:C0005684 | |
| Disease | Malignant tumor of cervix | 3.02e-04 | 4 | 211 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 3.02e-04 | 4 | 211 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 3.02e-04 | 4 | 211 | 2 | 188470 | |
| Disease | NEVUS, EPIDERMAL | 3.02e-04 | 4 | 211 | 2 | 162900 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 3.02e-04 | 4 | 211 | 2 | C4011754 | |
| Disease | Transitional cell carcinoma of bladder | 3.02e-04 | 4 | 211 | 2 | C0279680 | |
| Disease | synucleinopathy (biomarker_via_orthology) | 3.02e-04 | 4 | 211 | 2 | DOID:0050890 (biomarker_via_orthology) | |
| Disease | Thyroid cancer, nonmedullary, 2 | 3.02e-04 | 4 | 211 | 2 | cv:C4225426 | |
| Disease | Epilepsy, Cryptogenic | 3.11e-04 | 82 | 211 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 3.11e-04 | 82 | 211 | 5 | C0751111 | |
| Disease | Aura | 3.11e-04 | 82 | 211 | 5 | C0236018 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 3.21e-04 | 19 | 211 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 3.21e-04 | 19 | 211 | 3 | C1843181 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGYSVVEMNASDDRS | 391 | Q8WVB6 | |
| YSQASLGMDIHASDL | 1291 | P53355 | |
| LDTAFMYSDGQSETI | 71 | O43488 | |
| EDPLAADGVYTASQM | 406 | Q96BA8 | |
| SLNEASMDEYLGSLG | 216 | Q9NP73 | |
| LGQALLSSMDQEYAG | 11 | Q8IVF6 | |
| NGEATMLFAELTYTL | 176 | Q7L5N1 | |
| LELEMNSESEDGAYL | 261 | Q96RT6 | |
| LSLSVGDDMNSFLTY | 121 | Q96M83 | |
| TDEENDMLDLAYGLT | 131 | P10109 | |
| DANMVEGTAYLSSFL | 181 | Q9UHK6 | |
| SLSNYAVLMDLTGSE | 736 | Q8IWK6 | |
| SVYESEADQLLGNTM | 441 | Q86TY3 | |
| YSSMDAVAQVTLEDL | 991 | P54756 | |
| MESVALYSFQATESD | 1 | Q8TC17 | |
| MESVALYSFQATESD | 1 | Q13588 | |
| LGQALLSSMDQEYAG | 11 | A2A2Z9 | |
| IYDILQSSNMADGDS | 106 | Q9NVT9 | |
| RAASQSAMLQLDYGD | 116 | Q9BXJ3 | |
| SDMAVNYENTLIAAG | 226 | Q6RI45 | |
| EDDFLNNAMSSLYSG | 196 | Q8N6T3 | |
| TNYDEAAMAIASLNG | 351 | P26378 | |
| IETDSGYNSMDLAVA | 276 | Q9H9E1 | |
| MAAEAAYQTGADQAS | 166 | Q9NR28 | |
| GSSLMESEVNLDRYQ | 331 | P11532 | |
| EMENSNGSYLNDSIS | 3446 | P11532 | |
| EMTAGASDYFSLVSV | 166 | Q9HBB8 | |
| GEMDTTSYDVSVLNS | 651 | P33151 | |
| LVESGAAVFAMTYSD | 1011 | Q13625 | |
| GTVYILDAMSLENES | 671 | Q8TBY9 | |
| LDTAGQEEYSAMRDQ | 56 | P01112 | |
| LDTAGQEEYSAMRDQ | 56 | P01116 | |
| LDTAGQEEYSAMRDQ | 56 | P01111 | |
| TEMLQDAFSLLAYSD | 536 | Q6VN20 | |
| AYADDNSLLFMETSA | 151 | P51148 | |
| AMENSVSEASLYLQD | 1156 | Q9H0J4 | |
| NSTEDIMSLSTQGDY | 176 | O14966 | |
| EANEVTDSAYMGSES | 301 | O75154 | |
| LDEYTSELMLGGTNT | 396 | Q9NPH2 | |
| YAEVGDSASMEQSLL | 801 | Q14207 | |
| SGSMNIYLVLDGSDS | 266 | P00751 | |
| YLSPALDAQESMGSV | 661 | Q8TAB3 | |
| SSSYSEANEPDLQMA | 726 | Q5VWQ8 | |
| TGAVSTSENLDYELM | 516 | Q14517 | |
| SNDYEAKVAMLSGAL | 316 | Q8NA72 | |
| TMALQYGSESEEDAA | 346 | Q86U86 | |
| DIAYSFNTDMSADIL | 276 | Q9Y5H8 | |
| NIADYALSAGTTAMN | 1721 | Q9NU22 | |
| VYDRDLTTSDFMGSA | 261 | Q6DN12 | |
| SLGLTYDGMLSDVQS | 206 | P43363 | |
| DMFYGLSLIEVDTSE | 361 | Q8TD90 | |
| DASQYGTLLMVDSEE | 686 | Q14703 | |
| NDAEISSLYDAMVAA | 1211 | Q2M2H8 | |
| DVDDAAYSMSTGAVV | 2531 | O95714 | |
| VTSYTDIADLMDAGN | 186 | O60333 | |
| AMVAALSPADINYDE | 326 | O60333 | |
| YDRAGEMASSAQDES | 856 | O60333 | |
| GIRDSAFSMESIDDY | 186 | O43561 | |
| LIDNDAASMESLYDL | 171 | Q8WVP7 | |
| NDSEISSLYDEMVAA | 2151 | O43451 | |
| ANYSIIDDATMSDGL | 2116 | Q2LD37 | |
| YAAAALGVSNAAMED | 1106 | O60318 | |
| YSSMSDTNLAEAGLN | 1981 | Q9UPA5 | |
| STMGTLRDYADADIN | 761 | Q86SJ6 | |
| NALMAYSILDGEGSE | 291 | Q86UP0 | |
| YSDSLTAAMIDAVLD | 681 | Q86VP6 | |
| ALRFLGSNDEEMSYD | 1731 | P12107 | |
| LIMTRDSDGYENSTD | 216 | Q9H501 | |
| LLDMDFQAYLASSSE | 531 | Q9H501 | |
| LEGYSILDNNAATML | 1506 | A6NKB5 | |
| LEGYSISDNNAASML | 1461 | Q9H6A9 | |
| ISDQDMSAYLAEQSR | 1826 | Q9UIW2 | |
| LISDEDSADMFSLVY | 186 | P51805 | |
| LLADSTDGMASVAAY | 406 | P51805 | |
| ASYQEMNSALAELSG | 1836 | Q9ULL4 | |
| EGEENLDSYAGMSAI | 681 | P55157 | |
| LDSYAGMSAILFDVQ | 686 | P55157 | |
| KNAEIAYSLDSSVMG | 566 | O60245 | |
| AYSLDSSVMGIFAID | 571 | O60245 | |
| TNSELALMYNDESVL | 461 | Q07343 | |
| LSMLGQSDAYGAADA | 611 | P50542 | |
| ASLYDGSMLAALENV | 156 | O00748 | |
| LSTANENDGYVDMSS | 811 | Q6ZNL6 | |
| TYTMGEASVASLLED | 101 | Q2M1P5 | |
| LYSLTETASQEAMGL | 136 | P62502 | |
| YPMGSAEALELQDSA | 481 | Q9Y2L9 | |
| ELQYMGDESSANSSS | 326 | Q9BRS8 | |
| LTTSDGNAESLYMQG | 166 | Q7L4E1 | |
| PSNILYMDESASADS | 546 | Q9UK32 | |
| EALTSEAMEQRAAYG | 421 | Q96FT7 | |
| AYGILMATTSRDSAD | 751 | Q9ULB1 | |
| ILRSEYSSGMEADIA | 786 | Q9H8H2 | |
| EALLSLGQYSMADFT | 31 | P42694 | |
| DYSSQNDILMLGAVG | 386 | P17301 | |
| MAELYGAANQDSGVS | 316 | O43347 | |
| AEYPMQGELASAISS | 241 | Q7LFL8 | |
| NAEEYSDISEMRSLS | 826 | Q9Y2A7 | |
| SMDTNGSYTANDLDE | 631 | Q9NXE4 | |
| GSYTANDLDEMGQDS | 636 | Q9NXE4 | |
| LTTSVDNSEYMGNGD | 491 | A2A3N6 | |
| LVTNSMAGSVAESYD | 796 | O95248 | |
| YEGSAEMSSDLHSLA | 516 | Q9UMZ3 | |
| VVYTVLASDMDAGNN | 1846 | Q6V1P9 | |
| MALYVDGTQVASSLD | 376 | Q9BXP8 | |
| DTAGYNAMEESVSRE | 1621 | P38398 | |
| GSDILDNMSDSFYVT | 2561 | Q8NCM8 | |
| GAMVLTTNYDNLLEA | 141 | Q9NWS6 | |
| DIAGLASAIDMSTNY | 1871 | P04114 | |
| DMYAQDSIELLTTSG | 106 | Q9UIV1 | |
| NVMDSSNGLSEYLDL | 301 | Q6YHK3 | |
| AMKYGNDSSAELSEL | 6 | P23508 | |
| AAMAGQEETSQDETY | 1906 | Q13936 | |
| DYESESGSMISQTVA | 1276 | Q96N67 | |
| IYAEMAGSSLENIQE | 41 | Q9Y6W3 | |
| ESAIDFSAYIDSMAA | 56 | P49716 | |
| DILLGSTDYSTQIDM | 331 | Q00536 | |
| TINMDGTALYEALAA | 396 | P43003 | |
| ENMGLYEDLSSAGDI | 526 | O15360 | |
| NGDVDLTSDRYSMVG | 81 | Q12860 | |
| NTEGVALASYGMEDE | 201 | Q96CU9 | |
| ASFEDGLYMQSVVDA | 336 | Q3B7J2 | |
| TVNMDGTALYEALAA | 421 | P48664 | |
| KANDADTGSNADMTY | 291 | Q13634 | |
| DTGSNADMTYSIING | 296 | Q13634 | |
| LASIAENMEGYSGAD | 406 | O75449 | |
| EALSMGNATFYEVES | 936 | Q13753 | |
| LNTVASADSMSIYDD | 206 | P36542 | |
| DMYSQDSIDLLANSG | 106 | Q9UFF9 | |
| GEQDTEAYDMSALRS | 676 | Q9UJ99 | |
| MDNYADLSDTELTTL | 1 | P50402 | |
| FSDLNSTRGDADMYD | 61 | P50402 | |
| GATMEQDLYQLAESV | 446 | Q12929 | |
| ALALANSDSMYIEDL | 346 | O95718 | |
| EGLSMDSHLYASNIS | 396 | Q16099 | |
| EDTELQGMNEYLSSF | 1266 | Q14839 | |
| YMSNTTDVELAGLDG | 771 | P53992 | |
| EMQDELSYFLVDSAG | 361 | Q9NTJ5 | |
| QITYTMDTEDSEGNL | 2801 | Q9NZJ4 | |
| SSAEALEAAVSPMDY | 521 | Q68D06 | |
| SYMDASLISLIEDFG | 96 | Q5VV67 | |
| NMDGTALYEAVAAVF | 366 | P43005 | |
| TAMEQLYTLGALDDE | 956 | Q14562 | |
| ESFLEYMNNVLSSGE | 3021 | Q8TE73 | |
| MLDGSYSESEANSLA | 376 | P28476 | |
| LSEANVERLYAASDM | 136 | Q86V97 | |
| AMVAALSPADINYDE | 326 | Q12756 | |
| EYNLDQEDSSGMTLV | 591 | Q99549 | |
| TIDGESSNYINAALM | 1221 | Q15262 | |
| DGESSNYINAALMDS | 1236 | P28827 | |
| DSLGVSVMATDQDSY | 536 | Q8TB24 | |
| SVDNFYILMTEGALD | 396 | Q9Y5E1 | |
| LDAELTAMAGESYSR | 1571 | P42345 | |
| GATAAVLQSDTMDHY | 46 | O43427 | |
| TLVTVMAGNDENYSA | 101 | Q01196 | |
| SREYGFENSMDLAAI | 276 | Q8TDW5 | |
| ATSSLGIMDLDIYQE | 1551 | Q2M3C7 | |
| SNSDILTIYDGDEVM | 676 | Q9BYH1 | |
| ELQMDSAAGSAAGLY | 166 | A6NEV1 | |
| GISTFTDEDNAMYLL | 116 | P27169 | |
| ASSMDDLLAITGFNT | 21 | A6NJY1 | |
| SIEDSMNSYGSEGNL | 66 | Q9H426 | |
| TSDDSAVNMYILHSG | 296 | A2VDJ0 | |
| LSTSQSMEEDHGSLY | 181 | P0DP42 | |
| TAAAIFTVQMDDYLG | 76 | Q9Y6U3 | |
| LMGYLQVSEGSDLSN | 516 | Q96NR3 | |
| VDNYMFDDDESTLGS | 291 | Q5QGS0 | |
| FSNNEMSLSDIEIYG | 86 | Q86UY8 | |
| TAEGDMAYLSENVSK | 101 | Q9Y2N7 | |
| DENGTSVAEYPMSAS | 126 | Q86XR5 | |
| DLQDMSEISPYSGSA | 561 | Q92786 | |
| QSSAVMALQEASEAY | 86 | Q71DI3 | |
| RGYVDQEMETALSSS | 1066 | P58107 | |
| LSARDVMAAYGLSEQ | 271 | Q6P5W5 | |
| NTDNMSILGLTIDYG | 336 | Q9BVL4 | |
| GELLAQYMADAASEL | 91 | Q9NR46 | |
| SSAEALEAAVSPMDY | 521 | Q7Z7L1 | |
| YATSMGSREQLAIAE | 426 | P17987 | |
| VADKTAYLMGLNSSD | 381 | P11055 | |
| DADKSAYLMGLNSAD | 381 | P13533 | |
| DSYDLNSILQDMGIT | 306 | Q96P63 | |
| NLAELENYMGLSLSS | 46 | Q9H190 | |
| SMDLSTVGLNYLEEE | 556 | Q8WXE9 | |
| VNGELKSSYNDSDAM | 171 | Q8TED9 | |
| LELENEDVYMASTFG | 371 | O75891 | |
| SEAEDASLLSFMQGY | 21 | P02656 | |
| DDYLSDGMNSPELAA | 646 | Q16280 | |
| TYQELLGLSFEQMTD | 396 | Q9BYT8 | |
| AALAAGYSENIEMVT | 341 | O43298 | |
| DIYQATESEAGDMDL | 61 | Q9Y4G8 | |
| SLDEQGAAAIYTTQM | 71 | P09327 | |
| AGAAMEEASPYSLLD | 6 | Q9C0D3 | |
| SSLEVLHEMDDYGNT | 86 | O75762 | |
| YHSELNMSSLELGDS | 101 | A0A0A6YYD4 | |
| AASMSGDDNLEDDYL | 546 | Q9Y2W6 | |
| GYEMSINDTDVLESF | 496 | Q13129 | |
| AADAGSYMATATNEL | 786 | Q15772 | |
| EESTNDISHYLGMLD | 601 | Q8WYR1 | |
| NEDTELMAIYTTENG | 51 | Q9UGH3 | |
| YATSISMAQASDGLS | 1036 | Q12767 | |
| EAGIPAMSTNDLYAT | 326 | A6NJ88 | |
| SMDELAAFADSYGQR | 426 | Q71H61 | |
| MASVYLEEGNLENAF | 61 | Q96FJ0 | |
| LDMDNLYEDTVSGIN | 91 | A6NMA1 | |
| LYGASESSNMEVDIG | 346 | Q9NZV5 | |
| LGMSLSSFNLDDTEV | 356 | P10828 | |
| EVSANTEDSSMSGYL | 1326 | Q6ZV73 | |
| VSAEDETLAEYMGQT | 91 | Q92752 | |
| SDNSAENIALVTSMY | 256 | Q9Y5S1 | |
| MAALRYAGLDDTDSE | 1 | Q9NZC7 | |
| LRYSLADEASMDSGA | 201 | Q9UQQ2 | |
| NASDLLDIGYMGSNS | 1356 | Q9HCK4 | |
| IYLADMNSSESVGSD | 51 | Q99986 | |
| DSLITEALNGMEYQS | 841 | Q96JG9 | |
| SSDAVNLDRMYDLVA | 286 | P62068 | |
| LSTGTLAFEDIYMDQ | 946 | Q01118 | |
| QALIAEAVGSYDTMD | 901 | Q6PGP7 | |
| SYLNSANVEAGSADM | 1076 | Q9C0G0 | |
| NESQDYLLMDSELGE | 26 | Q9Y210 | |
| LSLMASLVAYDDSDS | 6 | Q64LD2 | |
| MEEAGDEIVSNAISY | 396 | Q7Z2W7 | |
| TSMFDDYQGDSSTLL | 1236 | P17948 | |
| MDEESLESALQTYRA | 1 | Q8N5A5 | |
| SAEALTALMDFAYTA | 81 | O95365 | |
| MDSTEAQLRYGSALA | 1846 | O95071 | |
| IEASLDVQYLMSAGA | 271 | O14773 | |
| QGAYSMDTAQFDELI | 1086 | P82987 | |
| DDTDGYTMTSVLQQL | 1541 | Q9NQX4 | |
| MQEAGADAILELAYT | 266 | P22033 | |
| ADSSENLNMESEYAI | 2376 | B2RTY4 | |
| NDIYELDTSGLEDTM | 781 | Q14CX7 |